Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 11.32B | 8.01B | 6.46B | 14.46B | 14.06B |
Gross Profit | 8.81B | 6.14B | 5.14B | 3.78B | 2.61B |
EBITDA | 3.74B | 2.28B | 2.96B | 1.31B | 537.96M |
Net Income | 1.95B | 1.03B | 2.11B | 335.86M | 101.71M |
Balance Sheet | |||||
Total Assets | 23.88B | 19.20B | 17.86B | 7.34B | 5.65B |
Cash, Cash Equivalents and Short-Term Investments | 2.86B | 2.50B | 2.88B | 1.48B | 1.09B |
Total Debt | 10.22B | 8.07B | 8.89B | 2.24B | 1.37B |
Total Liabilities | 15.18B | 11.91B | 12.82B | 4.60B | 2.99B |
Stockholders Equity | 7.89B | 7.25B | 4.99B | 2.72B | 2.66B |
Cash Flow | |||||
Free Cash Flow | 2.06B | 279.72M | 630.17M | 417.46M | -164.41M |
Operating Cash Flow | 2.36B | 1.14B | 1.39B | 1.14B | 431.30M |
Investing Cash Flow | -1.15B | -831.13M | -5.97B | -1.27B | -1.46B |
Financing Cash Flow | -905.00M | -836.98M | 5.93B | 316.41M | 912.44M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥18.93B | 11.62 | ― | 41.30% | 130.14% | ||
71 Outperform | ¥22.83B | 16.94 | 0.31% | -5.81% | 1585.94% | ||
66 Neutral | ¥7.32B | 12.40 | 4.45% | -2.17% | 25.33% | ||
63 Neutral | €14.20B | -11.72 | 1.40% | 3.93% | 2.00% | 1.26% | |
41 Neutral | ¥7.84B | ― | 5.38% | 6.34% | -367.82% |